You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nk cells infusion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Chengdu (Allogeneic Hematopoietic Stem Cell Transplantation)

Recruiting
  • Hematologic Malignancy
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Mar 12, 2022

Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))

Recruiting
  • Malignant Sarcoma
  • Natural Killer (NK) cells (a new immunotherapy)
  • Madrid, Spain
    Hospital Universitario La Paz
Jul 19, 2023

ACUTE LEUKEMIA Trial in Madrid (Donor IL-15 stimulated NK cells infusion)

Completed
  • ACUTE LEUKEMIA
  • Donor IL-15 stimulated NK cells infusion
  • Madrid, Spain
    Hospital General Universitario Gregorio Marañón
Sep 2, 2021

Colon Cancer Stage I Trial in Taoyuan (Magicell-NK contains NK cells suspended in 100 mL normal saline)

Recruiting
  • Colon Cancer Stage I
  • Magicell-NK contains NK cells suspended in 100 mL normal saline
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou
Sep 28, 2022

Multiple Myeloma Trial in Madrid (NKAE cells infusion, Lenalidomide, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • NKAE cells infusion
  • +2 more
  • Madrid, Spain
    Hospital Universitario 12 de Octubre
Aug 19, 2021

Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • Haplo SCT with NK cells
  • Haplo SCT
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021

Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)

Active, not recruiting
  • Ewing Sarcoma
  • +4 more
  • Allogeneic HCT
  • Donor NK Cell Infusion
  • Milwaukee, Wisconsin
  • +1 more
Apr 5, 2022

High-risk Leukemias Trial in Spain (NK cells stimulated ex vivo with IL-15, Alloreactive NK cells)

Recruiting
  • High-risk Leukemias
  • NK cells stimulated ex vivo with IL-15
  • Alloreactive NK cells
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Mar 30, 2022

Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

Recruiting
  • Acute Myeloid Leukemia
  • allogenic NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • allogenic CD19-CAR-NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 11, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult Trial in Nijmegen (UCB-NK cells, IL-2)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Nijmegen, Netherlands
    Radboud University Medical Center
Nov 10, 2021

Adult Acute Myeloid Leukemia in Remission Trial in Bologna (Alloreactive NK cell infusion)

Recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • Alloreactive NK cell infusion
  • Bologna, BO, Italy
    Antonio Curti
Jan 18, 2021

Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • anti-CD19 CAR NK cells (KN5501)
  • Shanghai, China
    Changhai Hospital
Aug 25, 2023

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Refractory Metastatic Colorectal Cancer Trial in Guangzhou (CAR-T infusion)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • CAR-T infusion
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Guangzhou Medical University
Feb 9, 2022

B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

Recruiting
  • B-Cell Lymphoblastic Leukemia/Lymphoma
  • Anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022

NSCLC Trial in Taipei city (donor-derived NK cell infusion)

Recruiting
  • Non-small Cell Lung Cancer
  • donor-derived NK cell infusion
  • Taipei city, Taiwan
    Tri-Service General Hospital
Aug 24, 2021

Acute Myeloid Leukemia Trial in Beijing (chemo combined with NK cells infusion)

Not yet recruiting
  • Acute Myeloid Leukemia
  • chemotherapy combined with NK cells infusion
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Sep 30, 2020

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Biospecimen Collection
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 30, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

Withdrawn
  • B-cell Lymphoma
  • B-cell Leukemia
  • anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 31, 2022

Solid Tumors Trial in Houston (Rimiducid, TROP2-CAR-NK Cells, Fludarabine phosphate)

Not yet recruiting
  • Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia Recurrent
  • CD123-CAR-NK cells
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022